Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial
Englisch et al.
J Psychopharmacol 2009;23:875-882.
ABSTRACT
Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Chakos et al.
Psychiatr. Serv. 2006;57:1094-1101.
ABSTRACT
| FULL TEXT
Patterns and Quality of Treatment for Patients With Schizophrenia in Routine Psychiatric Practice
West et al.
Psychiatr. Serv. 2005;56:283-291.
ABSTRACT
| FULL TEXT
Diagnosis and Treatment of Mood Disorders That Co-occur With Schizophrenia
Escamilla
Psychiatr. Serv. 2001;52:911-919.
ABSTRACT
| FULL TEXT
Suicide and schizophrenia
Siris
J Psychopharmacol 2001;15:127-135.
ABSTRACT
Depression in Schizophrenia: Perspective in the Era of "Atypical" Antipsychotic Agents
Siris
Am. J. Psychiatry 2000;157:1379-1389.
ABSTRACT
| FULL TEXT
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
Millan et al.
J Psychopharmacol 2000;14:114-138.
ABSTRACT
Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms
Levinson et al.
Am. J. Psychiatry 1999;156:1138-1148.
ABSTRACT
| FULL TEXT
Antidepressant Prescribing Practices of Outpatient Psychiatrists
Olfson et al.
Arch Gen Psychiatry 1998;55:310-316.
ABSTRACT
| FULL TEXT
Pharmacotherapy of Impaired Affect in Recovering Schizophrenic Patients
Hogarty et al.
Arch Gen Psychiatry 1995;52:29-41.
ABSTRACT
The Vicissitudes of Neurasthenia in Chinese Societies: Where Will It Go From the ICD-10?
Lee
Transcultural Psychiatry 1994;31:153-172.
ABSTRACT